Week 266 Review - Misery as Optibiotix continues to fall

Another horrible week, with many stocks falling and OPTI:Optibiotix slipping another 4p back down below 50p. There seems no end to these doldrums. I thought things were supposed to pick up in September? The combined portfolios lost £4,822 which widened the deficit between cost and value to £30,729 and reduced the portfolio value to £89,877.

Worst performer was MMX:Minds + Machines which dropped 11% for absolutely no reason at all. It's really annoying as they were looking like they had some momentum, and I've decided I want to sell them to invest in ITV:ITV which is one of my magic formula shares which is seemingly a massive bargain right now.

IQE:IQE dropped 7% presumably on the back of the American tech sell-off. The difference is those tech companies had all been soaring at record levels and have corrected, whereas IQE have been in a slump, and now have got even worse. One could suggest that's not fair.

OPTI:Optibiotix dropped 6% on no news and general disillusionment despite everything going to plan and looking really good. I think all the long term holders have run out of spare cash to buy any more, and potential investors are put off by the wild swings up and down as traders fill their boots.

DDDD:4D Pharma suffered some profit taking after the recent meteoric rise and also fell 6% this week, but they are still 152% up so I can't complain.

There was only one share that increased by a big margin this week, so Share of the Week goes to FXPO:Ferrexpo which climbed 5% after declaring a special dividend and are now back in profit in my account.

Bad - very bad indeed.

Some consolation that we're still above the trend line, but only just

The ISA and share portfolios look like this

			Weekly Change
Cash	£6.98		+£0
Portfolio cost	£62,366.49		+£0
Portfolio sell value (bid price-commission)	£42,823.61	(-31.3%)	-£2,750.01
Potential profits	£1,510.09		+£142.15
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£0		+£0
Yr 6 Average monthly cash profit	-£5.42	(-0.1%)	+£1.08
Total Dividends	£1,343.15		+£0
Total Profit from sales	£20,426.61		+£0
Average monthly cash profit	£350.73	(6.7%)	-£1.32
(Sold stocks profit + Dividends - Fees  / Months)
Performance/Injection	10.1%		+0%
Compound performance	52%		+0%

Big drop in value but a tiny ray of sunshine as JLP:Jubilee Metals goes up a tiny amount and potential profits increase by £142.

Right back down to the injection line. I hoped we'd left that way behind, but the optimism of a few weeks ago has been dashed.

The trend line has switched back to a downwards slope, and we're below it. Drat!

Here's the SIPP after week 250

			Weekly Change
Cash	£64.44		+£0
Portfolio cost	£55,593.53		+£0
Portfolio sell value (bid price - commission)	£45,368.26	(-18.4%)	-£2,053.88
Potential profits	£2,896.30		-£23.00
Yr 5 Dividends	£96.37		+£0
Yr 5 Interest	£0.03		+£0
Yr 5 Profit from sales	£212.32		+£0
Yr 5 Average monthly cash profit	£16.96	(0.4%)	-£0.41
Total Dividends	£1,995.61		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£12,761.31		+£0
Average monthly cash profit	£245.61	(5.3%)	-£0.98
(Sold stocks profit + Dividends - Fees / Months)
Performance/Injection	7.9%		+0%
Compound performance	38%		+0%

Last week DDDD:4D Pharma protected the big drop in OPTI:Optibiotix, but not this week as value dropped by £2,053. The good news is that potential profits only dropped by £23 so my magic formula shares held up well.

Around halfway between cost and injection - resilient.

Still a good distance above the trend line, but it's proving stubborn to turn around.

The trading account looks like this after week 216

			Weekly Change
Cash	£220.72		+£0
Portfolio cost	£2,354.16		+£0
Portfolio sell value (bid price - commission)	£1,393.02	(-40.8%)	-£18.74
Potential profits	£0		+£0
Year 5 Dividends	£0		+£0
Year 5 Profit	£154.70		+£0
Yr 5 Average monthly cash profit	£83.79	(42.7%)	-£11.97
Dividends	£47.92		+£0
Profit from sales	£441.07		+£0
Average monthly cash profit	£9.81	(5.0%)	-£0.05
(Sold stocks profit + Dividends - Fees  / Months)

IQE:IQE put a downer on things, but the other shares helped limit the damage to £18. No sign of being able to sell anything for a long time.

A worrying slow decline

The trend line is getting steeper which is good, but we've now dipped below it which is bad.

Let's see how well the wish list performed. I suspect not very well

1. OPTI:Optibiotix SweetBiotix announcement. No OPTI announcements and a gradual tortuous decline.
   
2. SBTX to drop in price to 16p. We are getting closer, dropping from 21p to 19p this week. I'm starting to feel twitchy now as a good news RNS will make it rocket, but I've set my target for 16p so I'm going to stick to it. I just need a spurt from JLP:Jubilee Metals so I have more to spend.
3. TLOU:Tlou Energy announce de-watering has resumed. A flat week and still no announcement. I really need these to perk up.
   
4. IQE:IQE increase another 5% so we get a gradual climb to 100p. Hahahaha no way! Decline for 2 weeks on the trot now, so surely a 5% rise should be possible next week?
   
5. Six SIPP shares to stay in potential profit. So close to getting this one. FXPO:Ferrexpo went back into profit, but POLR:Polar Capital Holdings dropped to a 3% loss. Let's hope we can get all 6 in profit next week.
6. JLP:Jubilee Metals to announce permission to process platinum rich tailings at DCM. This was promised weeks ago. I'm definitely adding that we start production with the fine chrome plant as that ought to be ready by now.
7. OPTI:Optibiotix to get within 10% of profit. Well I may as well can this one as we're way below and it's going to take a while for that to turn around.
8. CAML:Central Asia Metals re-instate their dividend. Interim results are on Wednesday, so this one may come true, and if it does we should see a big correction upwards.